Anti-Tumor Activity of Orally Administered Gefitinib-Loaded Nanosized Cubosomes against Colon Cancer

Anti-Tumor Activity of Orally Administered Gefitinib-Loaded Nanosized Cubosomes against Colon Cancer

Gefitinib (GFT) is a tyrosine kinase inhibitor drug used as a first-line treatment for patients with advanced or metastatic non-small cell lung, colon, and breast cancer. GFT exhibits low solubility and hence low oral bioavailability, which restricts its clinical application. One of the most importa...

Full description

Saved in:
Bibliographic Details
Main Authors: Ahmed A. El-Shenawy (Author), Mahmoud M. A. Elsayed (Author), Gamal M. K. Atwa (Author), Mohammed A. S. Abourehab (Author), Mohamed S. Mohamed (Author), Mohammed M. Ghoneim (Author), Reda A. Mahmoud (Author), Shereen A. Sabry (Author), Walid Anwar (Author), Mohamed El-Sherbiny (Author), Yasser A. Hassan (Author), Amany Belal (Author), Abd El hakim Ramadan (Author)
Format: Book
Published: MDPI AG, 2023-02-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items